RedPath’s
PathFinderTG®

represents over 17 years of research and development and is clinically validated at an average 95% accuracy
rate across multiple organs, specimen types and diagnostic questions
for cancer.
About: Mission & Vision

 

RedPath's Mission is to facilitate superior disease diagnosis.

 

RedPath's Vision is to be recognized by clinicians, pathologists, patients and payors as the source for objective, definitive diagnosis and characterization of cancer resulting in optimal treatment,          outcomes and cost.

 

A cystic mass of the pancreas was found in a 29 year old: is this a benign or cancerous cyst?
Read More

 

The Bonding of BioBuds
Read

What pathology examination of your Esophageal Biopsy can tell your doctor about the health of your esophagus.
Read

More News

 

More Events